Relissa™
製品、イベント、会社情報などのインデナの文書を閲覧できます。
セクションに移動
See through science
Relissa™
スクロールして詳細を見る
Peer-reviewed science on Relissa™
A randomized, placebo-controlled study was conducted on 100 subjects with from mild sleep problems (PSQI score >5) or individuals experiencing mild/moderate depression, anxiety and stress. Mental and sleep health were measured at baseline and after 3 weeks of RelissaTM supplementation (200 mg Lemon Balm extract) (n=52) or placebo (n=48) 2 times a day.1
After 3 weeks of administration, the study showed a significant increase in quality of sleep in subjects belonging to the intervention group when compared to baseline levels and to the placebo group (p<0.0001) (Figure 1). Moreover, authors highlighted a relevant beneficial effect in mental wellbeing (WEMWBS Score) (p<0.0001) (Figure 2), as well as a reduction on scores for depression, anxiety and stress (DASS Score) (p<0.0001) (Figure 3).1
Figure 1. Graphical representation of the sleep health variation in placebo and supplemented groups after 3 weeks. The perceived sleep quality and disturbances were assessed using the PSQI Score.
Figure 2. Graphical representation of the mental wellbeing modulation in placebo and supplemented groups after 3 weeks. Measurements were assessed using the Warwick Edinburgh Mental Wellbeing Scale (WEMWBS).
Figure 3. Graphical representation of depression (A), anxiety (B) and stress (C) reduction in placebo and supplemented groups after 3 weeks. Measurements were assessed using the Depression and Anxiety Stress Scale (DASS).
BIBLIOGRAPHY
1. Bano A, et al. (2023) Front. Pharmacol. 14:1250560. doi: 10.3389/fphar.2023.1250560
